Quaker Wealth Management’s GSK GSK Stock Holding History

Quaker Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$55.8K	Buy	1,065 +200	+23%	+$10.6K	0.02%	159
2026 Q1	$47.7K	Sell	865 -42	-5%	-$2.28K	0.01%	167
2025 Q4	$44.5K	Buy	907 +42	+5%	+$1.96K	0.01%	179
2025 Q3	$37.3K	Hold	865	–	–	0.01%	190
2025 Q2	$33.2K	Buy	+865	New	+$33.1K	0.01%	206
2020 Q4	–	Sell	-4,240	Closed	-$200K	–	50
2020 Q3	$200K	Buy	4,240 +49	+1%	+$2.46K	0.11%	47
2020 Q2	$214K	Buy	+4,191	New	+$215K	0.13%	45

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Quaker Wealth Management's GSK Position: Q2 2026 in Review

Quaker Wealth Management increased its GSK (GSK) stake by 23% in Q2 2026, buying an estimated $10.6K and bringing the position to 1,065 shares worth $55.8K. The position accounts for 0.02% of the portfolio, ranked #159.

Quaker Wealth Management first reported a position in GSK in Q2 2020 and has held it in 7 quarters since. The position peaked at $214K in Q2 2020. 1,043 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Quaker Wealth Management held 1,065 shares of GSK worth $55.8K as of Q2 2026.
Quaker Wealth Management bought 200 GSK shares in Q2 2026, an estimated $10.6K.
GSK made up 0.02% of Quaker Wealth Management's portfolio in Q2 2026, its #159 holding.
Quaker Wealth Management first reported a position in GSK in Q2 2020 and has held it in 7 quarters since.
Quaker Wealth Management's GSK position peaked at $214K in Q2 2020.
1,043 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.